Acetylsalicylic acid Completed Phase 1 Trials for The Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral Aneurysm Basic Science

Indications	Status	Purpose	Phase
DBCOND0059899 (The Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral Aneurysm)	Completed	Basic Science	1

clinicaltrials.gov Identifier	Title	Drugs
NCT01710072	Aspirin Attenuates Inflammation in Human Cerebral Aneurysms	Acetylsalicylic acid (DB00945)